Showing results (761-770 of 841) with videos related to

Sort By:
Pageof 85
Biological Psychiatry|November 7, 2019
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for PsychosisG Paul Amminger, Barnaby Nelson, Connie Markulev, et al.
The Journal of Allergy and Clinical Immunology|December 18, 2010
Tight junction defects in patients with atopic dermatitisAnna De Benedetto, Nicholas M Rafaels, Laura Y McGirt, et al.
Frontiers in Psychiatry|June 30, 2020
Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Frontiers in Psychiatry|June 28, 2019
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Disease Models & Mechanisms|November 2, 2012
Preclinical research in Rett syndrome: setting the foundation for translational successDavid M Katz, Joanne E Berger-Sweeney, James H Eubanks, et al.
Neurology|May 13, 2009
Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron diseaseI Le Ber, A Camuzat, E Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2017
Transcriptional Mechanisms of Resistance to Anti-PD-1 TherapyMaria L Ascierto, Alvin Makohon-Moore, Evan J Lipson, et al.
Psychotherapy and Psychosomatics|September 14, 2017
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for PsychosisJessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, et al.
Bjpsych Open|September 8, 2022
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trialNicholas Cheng, Alison McLaverty, Barnaby Nelson, et al.
Brain, Behavior, and Immunity|October 8, 2021
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trialSubash Raj Susai, David Mongan, Colm Healy, et al.
Pageof 85